Figure S7. Analysis by IHC and FISH of ALK in ILS31007 tissue specimen. The FFPE specimens with tumor tissue (upper panel) and the paired NAT specimens (lower panel) were obtained from BioreclamationIVT. IHC (left panel) and FISH (right panel) analyses for ALK rearrangement were performed with, respectively, the N-Histofine ALK detection kit (Nichirei Biosciences; Tokyo, Japan) and the Vysis ALK break apart FISH probe kit (Abbott laboratories; Abbott Park, IL) at a commercial clinical laboratory, LSI Medience (Tokyo, Japan). Images were captured using standard settings by the BZ900 (Keyence; Osaka, Japan) (PPTX 754 kb
BACKGROUND: Anaplastic lymphoma receptor tyrosine kinase (ALK), ROS proto-oncogene 1, receptor tyros...
BACKGROUND: Anaplastic lymphoma kinase (ALK) rearrangement represents a landmark in the targeted the...
International audienceThe detection of ROS1 and ALK rearrangements is performed for advanced-stage n...
Figure S6. Summary of ALK, RET, or ROS1 fusion in 4 tumor tissue specimens. Plot of normalized value...
Figure S10. Western blotting analysis in a cancer cell line with ROS1 fusion. Cell lysates were harv...
Figure S5. RT-PCR analysis of ALK, RET, or ROS1 fusion in 4 tumor tissues. The mRNA expression of va...
Figure S2. Summary of ALK, RET, or ROS1 fusion in 37 cancer cell lines. Plot of normalized values ca...
Figure S1. RT-PCR analysis of ALK, RET, or ROS1 fusion in 37 cancer cell lines. The mRNA expression ...
Figure S11. Western blotting analysis in five cancer cell lines without any fusion gene. Cell lysate...
Figure S9. Western blotting analysis in three cancer cell lines with or without RET fusion. Cell lys...
Figure S4. Comparison of molecular weights between wild-type and fusion protein. After high exposure...
Patients with ALK gene rearrangements often manifest dramatic responses to crizotinib, an ALK inhibi...
Abstract Background Genetic alterations, including mutation of epidermal growth factor receptor or v...
Patients with ALK gene rearrangements often manifest dramatic responses to crizotinib, an ALK inhibi...
Cytologic sampling is the mainstay of diagnosing advanced lung cancer. Moreover, to select patients ...
BACKGROUND: Anaplastic lymphoma receptor tyrosine kinase (ALK), ROS proto-oncogene 1, receptor tyros...
BACKGROUND: Anaplastic lymphoma kinase (ALK) rearrangement represents a landmark in the targeted the...
International audienceThe detection of ROS1 and ALK rearrangements is performed for advanced-stage n...
Figure S6. Summary of ALK, RET, or ROS1 fusion in 4 tumor tissue specimens. Plot of normalized value...
Figure S10. Western blotting analysis in a cancer cell line with ROS1 fusion. Cell lysates were harv...
Figure S5. RT-PCR analysis of ALK, RET, or ROS1 fusion in 4 tumor tissues. The mRNA expression of va...
Figure S2. Summary of ALK, RET, or ROS1 fusion in 37 cancer cell lines. Plot of normalized values ca...
Figure S1. RT-PCR analysis of ALK, RET, or ROS1 fusion in 37 cancer cell lines. The mRNA expression ...
Figure S11. Western blotting analysis in five cancer cell lines without any fusion gene. Cell lysate...
Figure S9. Western blotting analysis in three cancer cell lines with or without RET fusion. Cell lys...
Figure S4. Comparison of molecular weights between wild-type and fusion protein. After high exposure...
Patients with ALK gene rearrangements often manifest dramatic responses to crizotinib, an ALK inhibi...
Abstract Background Genetic alterations, including mutation of epidermal growth factor receptor or v...
Patients with ALK gene rearrangements often manifest dramatic responses to crizotinib, an ALK inhibi...
Cytologic sampling is the mainstay of diagnosing advanced lung cancer. Moreover, to select patients ...
BACKGROUND: Anaplastic lymphoma receptor tyrosine kinase (ALK), ROS proto-oncogene 1, receptor tyros...
BACKGROUND: Anaplastic lymphoma kinase (ALK) rearrangement represents a landmark in the targeted the...
International audienceThe detection of ROS1 and ALK rearrangements is performed for advanced-stage n...